首页> Respiratory medicine> Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020].

Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020].

导出 LinkOut

翻译打印收藏纠错

第一作者： Neil,Martin

第一单位： Global Medical Affairs, GSK, Brentford, Middlesex, UK; University of Leicester, 4488, Institute for Lung Health, Leicester, UK. Electronic address: neil.2.martin@gsk.com.

作者： Neil,Martin ^[1] ; Alberto,Papi ^[2] ; Daniel J,Bratton ^[3] ; Robert,Chan ^[4] ; Peter H,Howarth ^[5] ; Carl B,Abbott ^[6] ; Oliver N,Keene ^[3] ; Elisabeth H,Bel ^[7]

作者单位： Global Medical Affairs, GSK, Brentford, Middlesex, UK; University of Leicester, 4488, Institute for Lung Health, Leicester, UK. Electronic address: neil.2.martin@gsk.com. ^[1] Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy. ^[2] Clinical Statistics, GSK, Stockley Park, Middlesex, UK. ^[3] Clinical Sciences, GSK R&D, Stockley Park, Middlesex, UK. ^[4] Global Medical, Global Specialty and Primary Care, GSK, Brentford, Middlesex, UK. ^[5] Global Medical Affairs, GSK, Research Triangle Park, NC, USA. ^[6] Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. ^[7]

关键词 Biologic Persistent asthma Treatment

医学主题词哮喘(Asthma);生物制品(Biological Products);人类(Humans)

DOI 10.1016/j.rmed.2020.106065

PMID 35090690

发布时间 2022-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交